(Pharmaceutical 24 Hours) Hugel successfully held ‘HELF Global Workshop’ inviting Tunisian medical staff, etc.

◆ Hugel successfully completes ‘HELF Global Workshop’ inviting Tunisian medical staff

Hugel announced on the 8th that it had recently successfully held the ‘HELF Global Expert Workshop’ for Tunisian healthcare professionals (HCPs).

‘HELF Global Expert Workshop’ is one of the detailed programs of HELF (Hugel Expert Leader’s Forum), Hugel’s representative global academic forum, and is a seminar inviting overseas medical experts in the beauty and plastic surgery fields. It was designed for academic exchange through active communication with global medical staff.

This event, held in conjunction with Acros, Hugel’s hyaluronic acid (HA) filler affiliate, was attended by 15 Tunisian medical staff, and the program consisted of a tour of domestic clinics and lectures.

First, Park Joo-hyuk, director of The Hill Dermatology Clinic, who attended as a speaker, gave a theoretical lecture on ‘HA filler treatment techniques for the facial area.’ Afterwards, a live-demo using Hugel’s HA filler brand ‘The Chaeum (export name: Revolax)’ was presented to help attendees understand. Director Park introduced HA filler treatment know-how to naturally improve the facial area and the latest aesthetic trends, increasing trust in Hugel’s product capabilities and domestic medical service level.

◆ LG Chem holds cosmetic filler ‘YSolution’ Leaders Forum

LG Chem is strengthening the differentiated identity of the company’s premium filler brand ‘Y Solution’.

LG Chem announced on the 8th that it invited Key Opinion Leaders (KOLs) of the hyaluronic acid filler ‘Y-SOLUTION’ and held a Leaders’ Forum to discuss product strengths and brand identity in depth. This event was prepared to reflect the voices of customers who consider quality and safety as the top criteria for product selection in global business strategies.

YSolution is a new filler lineup launched by LG Chem in 2018 by increasing the viscosity and elasticity of hyaluronic acid compared to the existing filler Yvoir. It reflects LG Chem’s proprietary S-HICE cross-linking technology (Sync-High concentration equalized cross-linking technology). It’s a product. This technology minimizes the amount of cross-linking agent added to ensure high biocompatibility of hyaluronic acid, a bio-derived material. It is characterized by a volume improvement effect with a small amount of cross-linking agent.

◆ Obtained two types of international standards for compliance management and information protection

Samsung BioLogics was awarded a total of three certificates, including international standard certification from the International Organization for Standardization (ISO) ▲ISO 37301 (Compliance Management System) ▲ISO 27001 (Information Security Management System) ▲ISO 27017 (Cloud Security Management System) 8 The day was revealed.

In particular, Samsung BioLogics was recognized for its compliance management capabilities by obtaining certification for the compliance management system ‘ISO 37301’ for the first time this year. ‘ISO 37301’ is a certification system that evaluates whether a company’s compliance management processes and policies are systematically established and operated in accordance with international standards. By acquiring compliance management system certification, Samsung BioLogics is now able to respond more effectively to the continuously changing business regulatory environment.

Samsung BioLogics was once again recognized as having a global top-level security management system by renewing the ‘ISO 27001’ certification for the information protection management system obtained for the first time in the industry in 2019 and the ‘ISO 27017’ certification for the cloud security management system acquired in 2022. Within the global CDMO industry, Samsung BioLogics is the only company that has acquired both ‘ISO 27001’ and ‘ISO 27017’, the most authoritative international standards for information protection.

◆ UBCare builds the EMR industry’s first AI contact center system

UBCare, a leading digital healthcare platform company, announced on the 8th that it has established the EMR industry’s first AI Contact Center (Artificial Intelligence Contact Center, AICC) system.

AICC is an intelligent customer center that supports customer consultation using AI technology. Using AICC, systematic customer management and personalized counseling services that incorporate AI-based innovative technology are possible, going beyond call center work that provides simple guidance and repetitive counseling tasks.

UBCare plans to build an AI contact center to supplement the consultation work that directly communicates with the continuously increasing number of doctors using the service and to improve the quality of customer service through call log analysis.

Through the automatic conversion function from voice information to text information, which is a core function of AICC, knowledge and information for handling inquiries will be automatically matched and provided to counselors based on issue keywords that arise during consultation. This is expected to provide faster problem resolution to customer requests and strengthen service responsiveness.

◆ Pharmaceutical and Biotechnology Association strengthens networking with pharmaceutical and bio experts in ‘Basel, Switzerland’

The Korea Pharmaceutical and Biotechnology Association delegation announced on the 8th that it held a networking event to exchange with experts in the global Big Pharma, biotech, and European life science fields in Basel, Switzerland on the 7th (local time).

This event was prepared as part of the ‘Swiss Basel Investment Agency KPBMA customized program’ operated by the association and Basel Area Business & Innovation to support domestic pharmaceutical companies entering Europe, and was held for the third time following 2022 and 2023. .

This event, held with the goal of promoting exchanges between the Korean biopharmaceutical industry and the Basel region of Switzerland and introducing the pipelines of Korean companies to European companies, was held under the theme ‘How to collaborate with South Korea’s leading pharmaceutical companies’. It was held under the theme of ‘innovators’.

Officials from the association’s global headquarters, Yuhan Corporation, and Dong-A ST participated as representatives, and more than 110 experts from global big pharma and biotech, such as Roche, Lonza, and Novartis, and European academia and research institutes, attended.

Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited